Skip to content

Preeti Kakkar

NPI 1154128429ActiveIndividual· Nuclear Medicine, Nuclear Imaging & Therapy· New York, NY

Nuclear Medicine, Nuclear Imaging & Therapy in New York, New York, licensed in NY, with an NPI issued in February 2025. Telix Pharmaceuticals reported $161.36 in payments in 2025, mostly food and beverage.

Overview

NPI1154128429
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedFeb 25, 2025
Last updated in NPPESFeb 25, 2025
Certified by providerFeb 25, 2025

Specialties and licenses

TaxonomyCodeLicenseState
Nuclear Medicine, Nuclear Imaging & Therapy Primary207UN0902X2003511052NY

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$161.36 · 2 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Telix Pharmaceuticals$161.362

What the 2025 payments were for

  • Food and Beverage$161.36 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Nuclear Medicine, Nuclear Imaging & Therapy providers in New York

All Nuclear Medicine, Nuclear Imaging & Therapy providers in New York